Most Awaited Q3 Sale is back. Upto 30% discount on every report.
Oral Anti Diabetes Drugs Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 August 09
SKU : PH2726
180 pages
Report Summary
Table of Content
List of Tables & Figures
Buy this report
Single User
Multiple User
Enterprise User
Request new version
FAQ’s
What is the Projected CAGR value of the Oral Anti Diabetes Drugs Market?
The Oral Anti Diabetes Drugs Market is expected to grow at a high CAGR of 8.0% from 2023 to 2030.
Who are the Key Players of Oral Anti Diabetes Drugs Market ?
The major global players in the market include Glenmark Pharma, Abbott, Biocon, Sanofi S.A., Sunpharma, Novartis, Novo Nordisk, Merck, GlaxoSmithKline, and Bristol-Myers Squibb among others.
Which region controlled the global market during 2023-2030?
North America region Controls the Oral Anti Diabetes Drugs Market during 2023-2030.
What are the drivers of the global oral anti-diabetic drug market?
The increasing prevalence of diabetes and the growing aging population are the two main drivers of the global oral anti-diabetic drug market growth.
Related Reports
pharmaceuticalsBasal Insulin (Long-Acting Insulin) Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 September 27
Starting from
$4350
pharmaceuticalsOral Anti Diabetes Drugs Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 August 09
Starting from
$4350
pharmaceuticalsDiabetes Therapeutics Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 October 19
Starting from
$4350
pharmaceuticalsDiabetic Neuropathy Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 September 22
Starting from
$4350
pharmaceuticalsType 2 Diabetes Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 April 18
Starting from
$4350
pharmaceuticalsDiabetic Neuropathic Foot Ulcers Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 October 10
Starting from
$4350